To say that were having a peptide culture moment is an understatement
The dramatic results seen in trials involved people with obesity
It is associated with an 82.4% reduction in liver fat and normalisation in 86% of cases with a weekly 12 mg dose over 24 weeks, in relation to visceral adipose tissue reduction, improved insulin sensitivity, decreased leptin levels, increased adiponectin, and favourable changes in lipid metabolism parameters and fibrosis markers such as Pro-C3.56 Amylin analogues in combination with GLP-1 receptor agonists: CagriSema Amylin is a 37-amino-acid peptide that is co-secreted with insulin by pancreatic beta cells.57 It shares structural similarity with peptides of the calcitonin family
Fitchett D, Inzucchi SE, Cannon CP, et al
Journal of Adolescent Health, 49 (5), 525-531
YG1699 is another dual SGLT1/2 inhibitor undergoing phase 1 clinical trials with results still being analyzed (NC05089617)